Peripheral Stem Cell Apheresis is Feasible Post (131)Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution

K Kraal; I Timmerman; HM Kansen; C van den Bos; J Zsiros; H Berg; S Somers; Eric Braakman; AML Peek; MM Noesel; CE van der Schoot; M Fiocco; HN Caron; C Voermans; GAM Tytgat

doi:10.1158/1078-0432.Ccr-18-1904

Peripheral Stem Cell Apheresis is Feasible Post (131)Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution

K Kraal, I Timmerman, HM Kansen, C van den Bos, J Zsiros, H Berg, S Somers, Eric Braakman, AML Peek, MM Noesel, CE van der Schoot, M Fiocco, HN Caron, C Voermans, GAM Tytgat

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1012-1021
Number of pages	10
Journal	Clinical Cancer Research
Volume	25
Issue number	3
DOIs	https://doi.org/10.1158/1078-0432.Ccr-18-1904
Publication status	Published - 2019

Research programs

EMC MM-02-41-04

Access to Document

10.1158/1078-0432.Ccr-18-1904

http://hdl.handle.net/1765/115015

Cite this

Kraal, K., Timmerman, I., Kansen, HM., van den Bos, C., Zsiros, J., Berg, H., Somers, S., Braakman, E., Peek, AML., Noesel, MM., van der Schoot, CE., Fiocco, M., Caron, HN., Voermans, C., & Tytgat, GAM. (2019). Peripheral Stem Cell Apheresis is Feasible Post (131)Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution. Clinical Cancer Research, 25(3), 1012-1021. https://doi.org/10.1158/1078-0432.Ccr-18-1904

@article{b3b696be68b14463ae58f4779d3c324a,

title = "Peripheral Stem Cell Apheresis is Feasible Post (131)Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution",

author = "K Kraal and I Timmerman and HM Kansen and {van den Bos}, C and J Zsiros and H Berg and S Somers and Eric Braakman and AML Peek and MM Noesel and {van der Schoot}, CE and M Fiocco and HN Caron and C Voermans and GAM Tytgat",

year = "2019",

doi = "10.1158/1078-0432.Ccr-18-1904",

language = "Undefined/Unknown",

volume = "25",

pages = "1012--1021",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "3",

}

Kraal, K, Timmerman, I, Kansen, HM, van den Bos, C, Zsiros, J, Berg, H, Somers, S, Braakman, E, Peek, AML, Noesel, MM, van der Schoot, CE, Fiocco, M, Caron, HN, Voermans, C & Tytgat, GAM 2019, 'Peripheral Stem Cell Apheresis is Feasible Post (131)Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution', Clinical Cancer Research, vol. 25, no. 3, pp. 1012-1021. https://doi.org/10.1158/1078-0432.Ccr-18-1904

TY - JOUR

T1 - Peripheral Stem Cell Apheresis is Feasible Post (131)Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution

AU - Kraal, K

AU - Timmerman, I

AU - Kansen, HM

AU - van den Bos, C

AU - Zsiros, J

AU - Berg, H

AU - Somers, S

AU - Braakman, Eric

AU - Peek, AML

AU - Noesel, MM

AU - van der Schoot, CE

AU - Fiocco, M

AU - Caron, HN

AU - Voermans, C

AU - Tytgat, GAM

PY - 2019

Y1 - 2019

U2 - 10.1158/1078-0432.Ccr-18-1904

DO - 10.1158/1078-0432.Ccr-18-1904

M3 - Article

SN - 1078-0432

VL - 25

SP - 1012

EP - 1021

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 3

ER -